List of insiders holdings for CHIMERIX INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Sanderling Venture Partners V LP Sanderling VI Limited Partnership Sanderling Ventures Management VI 10% Owner | 2013-11-15 18:13:06 | 0 4,255,826 | 4,255,826 | Form 4 |
| Sanderling Venture Partners V LP SANDERLING V BIOMEDICAL LP SANDERLING V LTD PARTNERSHIP SANDERLING V BETEILIGUNGS GMBH & CO KG SANDERLING VENTURES MANAGEMENT V SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP Sanderling Venture Partners V Co Investment Fund LP Sanderling V Strategic Exit Fund LP Sanderling Venture Partners VI Co Investment Fund LP Sanderling VI Beteiligungs GmbH & Co KG 10% Owner | 2013-11-15 18:14:44 | 0 4,255,826 | 4,255,826 | Form 4 |
| Sanderling Venture Partners V LP 10% Owner | 2014-09-16 14:52:36 | 0 3,930,700 | 3,930,700 | Form 4 |
| MIDDLETON FRED A Director | 2024-10-30 20:00:11 | 207,523 3,407,954 | 3,615,477 | Form 4 |
| CANTEX PHARMACEUTICALS INC. 10% Owner | 2022-02-03 16:16:00 | 3,500,000 0 | 3,500,000 | Form 13G |
| WOLLAEGER TIMOTHY Director | 2016-03-02 14:59:31 | 10,000 3,320,102 | 3,330,102 | Form 4 |
| Hutton Wende S Director 10% Owner | 2013-10-23 18:29:29 | 0 2,597,387 | 2,597,387 | Form 4 |
| CHAMPSI FARAH Director | 2013-10-23 18:31:08 | 0 1,714,330 | 1,714,330 | Form 4 |
| A.M. Pappas Life Science Ventures IV LP PV IV CEO Fund L.P. A.M. Pappas Life Science Ventures III L.P. PV III CEO Fund L.P. Stockholder | 2013-04-16 16:36:31 | 0 1,047,535 | 1,047,535 | Form 4 |
| PAPPAS ARTHUR M Director | 2013-10-23 18:27:36 | 0 830,695 | 830,695 | Form 4 |
| Riga Thomas J COO and CCO | 2023-11-16 18:54:43 | 800,000 0 | 800,000 | Form 4 |
| Sanderling Venture Partners VI Co Investment Fund LP 10% Owner | 2014-09-09 16:31:06 | 697,346 0 | 697,346 | Form 4 |
| Andriole Michael T. PRESIDENT AND CEO | 2024-08-09 12:01:08 | 462,453 0 | 462,453 | Form 4 |
| MOCH KENNETH I President and CEO | 2014-04-07 17:52:16 | 153,573 292,466 | 446,039 | Form 5 |
| Berrey M Michelle President and CEO | 2019-01-25 16:40:18 | 400,000 0 | 400,000 | Form 4 |
| Alrutz Michael Albert SVP AND GENERAL COUNSEL | 2024-02-02 18:30:06 | 299,348 0 | 299,348 | Form 4 |
| Nichols Garrett Chief Medical Officer | 2020-02-11 16:19:43 | 260,066 0 | 260,066 | Form 4 |
| Melemed Allen S. CHIEF MEDICAL OFFICER | 2024-02-02 18:28:43 | 255,180 0 | 255,180 | Form 4 |
| Trost Timothy W. SVP, CFO & Secretary | 2019-05-22 17:28:03 | 217,088 0 | 217,088 | Form 4 |
| Rogers Michael D. Chief Development Officer | 2016-01-12 20:08:03 | 178,000 0 | 178,000 | Form 4 |
| Jakeman David VP OF FINANCE AND ACCOUNTING | 2024-02-16 20:00:36 | 141,232 0 | 141,232 | Form 4 |
| ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC Stockholder | 2015-02-12 16:15:03 | 137,744 0 | 137,744 | Form 13G |
| MARIO ERNEST Director | 2018-05-21 13:34:29 | 12,905 108,167 | 121,072 | Form 4 |
| LaSpaluto Michelle CHIEF FINANCIAL OFFICER | 2024-02-16 20:01:37 | 110,999 0 | 110,999 | Form 4 |
| Vakiener Victoria Director | 2024-06-21 11:18:35 | 60,000 0 | 60,000 | Form 4 |
| Multani Pratik S Director | 2024-06-21 11:16:45 | 60,000 0 | 60,000 | Form 4 |
| Meyer Robert J. Director | 2024-06-21 11:12:58 | 60,000 0 | 60,000 | Form 4 |
| KOZIN MARC D Director | 2024-06-21 11:11:22 | 60,000 0 | 60,000 | Form 4 |
| Decker Lisa Lynn Director | 2024-06-21 11:09:41 | 60,000 0 | 60,000 | Form 4 |
| Gilliss Catherine Director | 2023-06-12 16:27:12 | 60,000 0 | 60,000 | Form 4 |
| Machado Patrick Director | 2023-06-12 16:28:17 | 60,000 0 | 60,000 | Form 4 |
| DEMSKI MARTHA J Director | 2024-06-21 11:08:04 | 60,000 0 | 60,000 | Form 4 |
| Sherman Michael A. Chief Executive Officer | 2024-06-21 11:05:52 | 60,000 0 | 60,000 | Form 4 |
| Richardson Linda M Chief Commercial Officer | 2018-05-15 13:42:15 | 54,161 0 | 54,161 | Form 4 |
| Greissing Ed Director | 2020-06-15 12:44:24 | 35,000 0 | 35,000 | Form 4 |
| NIEDEL JAMES Director | 2017-06-29 16:16:58 | 21,000 0 | 21,000 | Form 4 |
| Daly James M Director | 2019-06-24 14:35:40 | 21,000 0 | 21,000 | Form 4 |
| Renaud Ronald C JR Director | 2019-06-24 14:30:13 | 21,000 0 | 21,000 | Form 4 |
| LEONARD JOHN M. Director | 2017-06-29 16:19:57 | 21,000 0 | 21,000 | Form 4 |
| DRAKE RODMAN L Director | 2014-06-24 11:47:44 | 9,000 0 | 9,000 | Form 4 |
| Ricciardi Lisa Director | 2016-06-28 15:19:22 | 9,000 0 | 9,000 | Form 4 |
| Canaan VII L P Canaan Partners VII LLC Director | 2015-02-12 19:34:58 | 0 0 | 0 | Form 13G |
| New Leaf Ventures II L.P. New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. Chambon Philippe O. HUNT RONALD Lathi Vijay K Delagardelle Jeani Ratcliffe Liam 10% Owner | 2015-02-17 15:31:17 | 0 0 | 0 | Form 13G |